Summary of the sensing properties of green-synthesized CDsa.
Analyte | Method of detection | Limit of detection | Linear range | Ref. |
---|---|---|---|---|
As3+ | FQ | 2.3 nM | 2–12 nM | 54 |
ClO− | FQ | 16 nM | 10–90 μM | 54 |
Cr6+ | FQ | 4.5 ppb | 1.6–50 μM | 11 |
Cu2+ | FQ | 10 nM | 0–100 μM | 55 |
Fe2+ | FQ | 180 nM | 0–18 μM | 19 |
Fe3+ | FQ | 5 nM | 0.01–50 μM | 28 |
H2O2 | AI | 35 μM | 100–500 μM | 18 |
Hg2+ | FQ | 0.23 nM | 0.5–10 nM | 23 |
2,4,6-Trinitrophenol | FQ | 5 nM | 0.025–40 μM | 9 |
Adenosine triphosphate | FI | 5 nM | 0.01–450 μM | 33 |
Ascorbic acid | AI | 1.773 μM | 5–40 μM | 18 |
Dimercaptosuccinic acid | FI | 1.4 ng mL−1 | 2.5–22.5 ng mL−1 | 56 |
Chlortetracycline | FQ | 0.078 μg mL−1 | 0.85–20.38 μg mL−1 | 25 |
Cysteamine | FQ | 75.6 nM | 10–210 μM | 57 |
Doxorubicin | FQ | 0.4 ng mL−1 | 1–400 ng mL−1 | 58 |
Glutathione | FI | 1.7 μM | 0–20 μM | 26 |
Glyphosate | FI | 12 ng mL−1 | 0.025–2.5 μg mL−1 | 59 |
Imipramine | FQ | 0.6 ng mL−1 | 1.0–200.0 ng mL−1 | 34 |
Methotrexate | FQ | 7 nM | 0.02–18.0 μM | 10 |
Morin | FQ | 0.12 μM | 0.4–60 μM | 15 |
Penicillamine | FQ | 0.02 μg mL−1 | 0.05–13.0 μg mL−1 | 60 |
Prilocaine | FQ | 1.8 nM | 2.3–400 nM | 61 |
Pyridine | FI | 210 nM | 0.5–4.1 μM | 62 |
Salazosulfapyridine | FQ | 40 nM | 0.1–80 μM | 6 |
Sulfasalazine | FQ | 0.032 μg mL−1 | 0.34–6.76 μg mL−1 | 25 |
Trifluralin | FQ | 0.5 nM | 0.050–200 μM | 63 |
Zoledronic acid | FI | 40 nM | 0.1–10 μM | 35 |
FQ = fluorescence quenching, FI = fluorescence increase, AI = absorbance increase.